<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>369f01bf-7672-47f3-9008-6574d46d44d4</id>
  <name>Endocarditis Prophylaxis Pediatric Order Set</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~369f01bf-7672-47f3-9008-6574d46d44d4~NAME~Endocarditis Prophylaxis Pediatric Order Set}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;For IT -&amp;nbsp;&lt;u&gt;&lt;strong&gt;Prevention of Infective Endocarditis&lt;/strong&gt;&lt;/u&gt; (URL:&amp;nbsp;https://www.ahajournals.org/doi/10.1161/circulationaha.106.183095)&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;strong&gt;Prophylaxis for bacterial endocarditis&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;Cardiac Conditions Associated with the highest risk of adverse outcome from endocarditis for which prophylaxis with dental procedures is reasonable&amp;nbsp;&lt;br&gt;1.&amp;nbsp;&amp;nbsp; &amp;nbsp;Prosthetic cardiac valve or prosthetic material used for cardiac valve repair&amp;nbsp;&lt;br&gt;2.&amp;nbsp;&amp;nbsp; &amp;nbsp;Previous endocarditis&lt;br&gt;3.&amp;nbsp;&amp;nbsp; &amp;nbsp;Particular types of congenital heart disease (CHD):&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; a.&amp;nbsp;&amp;nbsp; &amp;nbsp;Unrepaired cyanotic CHD, including palliative shunts and conduits&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; b.&amp;nbsp;&amp;nbsp; &amp;nbsp;Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by &amp;nbsp; &amp;nbsp; catheter intervention, during the first 6 months after the procedure†&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; c.&amp;nbsp;&amp;nbsp; &amp;nbsp;Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization)&amp;nbsp;&lt;br&gt;4.&amp;nbsp;&amp;nbsp; &amp;nbsp;Cardiac transplantation recipients who develop cardiac valvulopathy&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Dental Procedures&lt;/strong&gt; for Which Endocarditis Prophylaxis Is Reasonable for Patients at high risk listed above.&lt;br&gt;1.&amp;nbsp;&amp;nbsp; &amp;nbsp;Procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa&lt;br&gt;&amp;nbsp;&lt;br&gt;The following procedures and events DO NOT need prophylaxis:&amp;nbsp;&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;routine anesthetic injections through non-infected tissue&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;taking dental radiographs&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;placement of removable prosthodontic or orthodontic appliances,&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;adjustment of orthodontic appliances&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;placement of orthodontic brackets&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;shedding of deciduous teeth&amp;nbsp;&lt;br&gt;○&amp;nbsp;&amp;nbsp; &amp;nbsp;bleeding from trauma to the lips or oral mucosa&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Gastrointestinal/Genitourinary Procedures:&amp;nbsp;&lt;/strong&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Antibiotic prophylaxis solely to prevent IE is no longer recommended for patients who undergo a GI or GU tract procedures including esophagogastroduodenoscopy or colonoscopy. &amp;nbsp;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;However, consider endocarditis prophylaxis for patients having&amp;nbsp;&lt;u&gt;gastrointestinal or genitourinary procedures&lt;/u&gt;&amp;nbsp;if there is either an existing infection or if antibiotic therapy is indicated for such procedures to prevent wound infection or sepsis.&amp;nbsp;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Consider using an antibiotic regimen which includes an agent that has activity against enterococci such as ampicillin or amoxicillin (or vancomycin if the patient is unable to tolerate a beta-lactam).&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Respiratory Tract Procedures&lt;/strong&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Antibiotic prophylaxis is not recommended for bronchoscopy unless the procedure involves incision of the respiratory tract mucosa.&amp;nbsp;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Consider endocarditis prophylaxis for patients having&amp;nbsp;&lt;u&gt;invasive respiratory tract procedures&lt;/u&gt;&amp;nbsp;to treat an established infection, such as abscess drainage, with an antibiotic regimen containing an agent active against viridans group streptococci (for example, amoxicillin or cefazolin), and if&amp;nbsp;Staphylococcus aureus&amp;nbsp;is known or suspected, an antistaphylococcal penicillin or cephalosporin (or vancomycin if the patient is unable to tolerate a beta-lactam or if suspected or known methicillin-resistant&amp;nbsp;S. aureus).&lt;br&gt;&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Dermatological and Musculoskeletal Procedures&lt;/strong&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Do not administer antibiotic prophylaxis for high-risk patients undergoing “clean” dermatological or MSK procedures.&amp;nbsp;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Consider endocarditis prophylaxis for patients having&amp;nbsp;&lt;u&gt;dermatologic or musculoskeletal procedures&amp;nbsp;&lt;/u&gt;involving infected skin (including oral abscesses), skin structures, or musculoskeletal tissue (&lt;u&gt;Weak recommendation&lt;/u&gt;).&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Other considerations:&lt;/strong&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Maintenance of optimal oral health and hygiene may reduce incidence of bacteremia from daily activities and may be more important than prophylactic antibiotics for dental procedures to reduce risk of infective endocarditis.&lt;br&gt;&amp;nbsp;&lt;br&gt;·&amp;nbsp;&lt;u&gt;&lt;strong&gt;Prevention of Infective Endocarditis&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Oral Medications&apos;]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;single select&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Unable to take oral medication&apos;]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;single select&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicllins or ampicillin - oral&apos;]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;single select&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicllins or ampicillin - oral&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;** Cephalosporin’s should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria with penicillins or ampicillin&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicillins or ampicillin and unable to take oral medication&apos;]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;single select&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicillins or ampicillin and unable to take oral medication&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;** Cephalosporin’s should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria with penicillin’s or ampicillin&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Endocarditis Prophylaxis Pediatric">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Guidance Text">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="PLACEHOLDER; to make guidance text display only. DO NOT Order this Communication Item"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Medication For Dental Procedures">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Oral Medications">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b689d593-074e-4521-b0d5-3b36ee37cd23" concept_name="PHARM AMOXICILLIN ORAL LIQUID ORDERABLE [4201149] Order" max="1" path="/items" name="amoxicillin Oral liquid; 50 mg/kg/dose, oral, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Unable to take oral medication">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM AMPICILLIN INJECTION ORDERABLE [420002] Order" max="1" path="/items" name="ampicillin injection; 50 mg/kg/dose, intravenous, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM AMPICILLIN INJECTION ORDERABLE [420002] Order" max="1" path="/items" name="ampicillin injection; 50 mg/kg/dose, intramuscular, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM CEFAZOLIN IM IV ORDERABLE [420006] Order" max="1" path="/items" name="ceFAZolin IV/IM; 50 mg/kg/dose, intravenous, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM CEFAZOLIN IM IV ORDERABLE [420006] Order" max="1" path="/items" name="ceFAZolin IV/IM; 50 mg/kg/dose, intramuscular, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #3"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM CEFTRIAXONE INJECTION ORDERABLE [420012] Order" max="1" path="/items" name="cefTRIAXone injection; 50 mg/kg/dose, intravenous, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM CEFTRIAXONE INJECTION ORDERABLE [420012] Order" max="1" path="/items" name="cefTRIAXone injection; 50 mg/kg/dose, intramuscular, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Allergic to penicllins or ampicillin - oral">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="166044b5-bcf6-45c2-b11b-220d8ef231fa" concept_name="PHARM CEPHALEXIN 250 MG 5 ML ORAL SUSPENSION [9502] Order" max="1" path="/items" name="cephaLEXIN liquid oral 50 mg/mL; 50 mg/kg/dose, oral, once, 30 - 60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5ea9d2e2-f60c-4452-9bce-0e1ce845191e" concept_name="PHARM CLINDAMYCIN 75 MG 5 ML ORAL SOLUTION [37642] Order" max="1" path="/items" name="clindamycin liquid oral 15 mg/mL; 20 mg/kg/dose, oral, once, 30 - 60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f373abf7-05df-496d-868b-599bb0b16afe" concept_name="PHARM AZITHROMYCIN 200 MG 5 ML ORAL SUSPENSION [15797] Order" max="1" path="/items" name="AZIthromycin liquid oral 40 mg/mL; 15 mg/kg/dose, oral, once, 30 - 60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3d9da0be-9853-499f-8aef-17c24dddc344" concept_name="PHARM CLARITHROMYCIN 250 MG 5 ML ORAL SUSPENSION [12886] Order" max="1" path="/items" name="clarithrymycin liquid oral 50 mg/mL; 15 mg/kg/dose, oral, once, 30 - 60 minutes prior to procedure"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Allergic to penicillins or ampicillin and unable to take oral medication">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM CEFAZOLIN IM IV ORDERABLE [420006] Order" max="1" path="/items" name="ceFAZolin IV/IM; 50 mg/kg/dose, intravenous, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM CEFAZOLIN IM IV ORDERABLE [420006] Order" max="1" path="/items" name="ceFAZolin IV/IM; 50 mg/kg/dose, intramuscular, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM CEFTRIAXONE INJECTION ORDERABLE [420012] Order" max="1" path="/items" name="cefTRIAXone injection; 50 mg/kg/dose, intravenous, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM CEFTRIAXONE INJECTION ORDERABLE [420012] Order" max="1" path="/items" name="cefTRIAXone injection; 50 mg/kg/dose, intramuscular, once, Preprocedure/Day Surgery, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #3"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="eae3d03c-57f0-4341-8e81-0577dfab869f" concept_name="PHARM CLINDAMYCIN INJECTION ORDERABLE [420015] Order" max="1" path="/items" name="clindamycin injection; 20 mg/kg/dose, intravenous, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="eae3d03c-57f0-4341-8e81-0577dfab869f" concept_name="PHARM CLINDAMYCIN INJECTION ORDERABLE [420015] Order" max="1" path="/items" name="clindamycin injection; 20 mg/kg/dose, intramuscular, once, 30-60 minutes prior to procedure"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">
    <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>
  </integrity_checks>
</template>